Frequently Asked Questions

Fluctuating ADHD was the most common long-term course, occurring in 63.8% of the sample. In this analysis of 483 participants with childhood ADHD who had at least 1 adult follow-up, the fluctuating subgroup included 335 individuals. The authors concluded that fluctuating ADHD may be the standard clinical course in this cohort rather than a rare variant.

No. In this study, endpoint status was a poor proxy for longitudinal course. Among participants classified as symptom persistent at the study endpoint, 80.1% were actually fluctuating over time, 15.5% showed stable persistence, 4.4% showed sustained partial remission, and 0.0% showed recovery.

Among those classified as symptom remitted at endpoint, 62.3% were fluctuating, 22.0% showed recovery, 15.7% showed sustained partial remission, and 0.0% showed stable persistence. Among longitudinal fluctuators specifically, 56.6% met endpoint criteria for symptom persistence and 43.4% met endpoint criteria for remission.

Fluctuating ADHD was characterized by repeated shifts between remission and recurrence over time. In the fluctuating subgroup, participants had a mean of 3.58 classification changes (SD = 1.36), about a 6- to 7-symptom difference between inattention and hyperactivity/impulsivity peaks and troughs, and a first remission period in early adolescence on average (mean age = 12.52 years, SD = 3.63).

The authors also reported relatively stable impairment despite symptom fluctuation, along with moderate rates of comorbidity, substance use, and treatment utilization over time.

The stable persistent group was much less common and clinically heavier than the fluctuating group. It represented 37 participants, or 10.8% of the sample, and was characterized by no ADHD classification changes, high symptom peaks and troughs with only about a 2- to 4-symptom difference, relatively high and stable impairment, comorbidity, and substance use over time, relatively low medication use, and relatively high psychosocial treatment utilization.

By contrast, the fluctuating group showed repeated remission and recurrence, larger symptom swings, and more moderate overall severity.

No. This analysis did not find a relation between baseline ADHD severity and longitudinal ADHD course. In contrast, after false discovery rate correction, the childhood factors that predicted longitudinal subgroup membership were parent SCID diagnoses, childhood mood disorder, childhood depression severity, and 36-month MTA treatment response.

The authors noted that prognosis may need to reflect a broader view of the child’s clinical and family context rather than symptom level at a single baseline assessment.

After false discovery rate correction, 4 childhood variables predicted longitudinal remission patterns: parent SCID diagnoses, childhood mood disorder, childhood depression severity, and 36-month MTA treatment response.

• The fluctuating and stable persistence subgroups had more parent SCID diagnoses at baseline than the recovery subgroup.
• The fluctuating, stable partial remission, and recovery subgroups had lower rates of childhood mood diagnoses than the stable persistence subgroup.
• The recovery subgroup had lower childhood depression severity than the stable partial remission subgroup.
• The fluctuating subgroup, and also the recovery subgroup, had a more favorable 36-month treatment response pattern than the stable persistent subgroup.

In this study, higher environmental demands were associated with remission rather than persistence among participants with fluctuating ADHD. After adjusting for age, each 1-point increase in a person’s average environmental demands score across time was associated with 1.58 higher odds of full remission versus persistence and 1.36 higher odds of partial remission versus persistence at a given time point.

For within-person change, each 1-point increase above an individual’s own average environmental demands at a given assessment was associated with 1.28 times higher odds of full remission versus persistence. The authors emphasized that these findings show concurrent association and do not establish whether remission enabled entry into more demanding settings or higher demands facilitated symptom management.

Yes. The study found a significant interaction between age and within-person environmental demands for full remission versus persistence. The association between higher-than-usual environmental demands and full remission was stronger at younger ages and became less closely related as individuals progressed through adulthood.

There was no significant within-person environmental demands effect, and no significant age interaction, for partial remission versus persistence.

Full remission required symptoms below the study’s full remission threshold according to all informants, no clinically significant impairment, and discontinuation of all ADHD intervention for at least 1 month before assessment. The symptom threshold for full remission was fewer than 3 inattention symptoms and fewer than 3 hyperactivity/impulsivity symptoms.

Persistent ADHD used a previously validated definition based on DSM-5 symptom thresholds of 5 or 6 symptoms in either inattention or hyperactivity/impulsivity depending on age, plus impairment rated at 3 or higher on the IRS or CIS. Partial remission was assigned when a participant met criteria for neither persistence nor full remission, such as low symptoms with ongoing impairment, high symptoms with insufficient impairment, or symptom and impairment remission while still receiving treatment.

The authors noted several limitations. The environmental demands measure was an imperfect index based on available information and assessed at 2-year intervals, which limited modeling of finer-grained or more complex temporal relationships.

The multilevel analyses focused on concurrent fluctuation of remission and demands, so they cannot determine causality or the direction of effects. The sample also included fewer girls than boys and fewer participants with minoritized racial or ethnic identities relative to white participants, which may limit generalizability. In addition, although prior work suggested informant switching explained minimal variance, some fluctuations could still reflect changes in informant perception rather than true behavioral change.

These findings support longitudinal monitoring rather than relying on a single time point to judge prognosis. Because fluctuating ADHD was common and endpoint classification often misrepresented long-term course, the authors concluded that clinicians should emphasize that ADHD often fluctuates over time and that monitoring symptoms is important to trigger as-needed return to care.

The authors also suggested partnering with patients and families to identify person-specific environmental factors that appear to positively influence functioning.